STATE STREET CORP - MERIDIAN BIOSCIENCE INC ownership

MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 180 filers reported holding MERIDIAN BIOSCIENCE INC in Q3 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of MERIDIAN BIOSCIENCE INC
ValueSharesWeighting
Q4 2022$104,833,940
+104.5%
3,156,698
+94.1%
0.00%0.0%
Q3 2022$51,271,000
+3.7%
1,626,105
+0.0%
0.00%0.0%
Q2 2022$49,463,000
+15.0%
1,625,997
-1.9%
0.00%
+50.0%
Q1 2022$43,009,000
+21.4%
1,656,733
-4.6%
0.00%0.0%
Q4 2021$35,420,000
+0.4%
1,736,298
-5.3%
0.00%0.0%
Q3 2021$35,279,000
-11.4%
1,833,610
+2.1%
0.00%0.0%
Q2 2021$39,834,000
-9.6%
1,795,951
+7.0%
0.00%
-33.3%
Q1 2021$44,057,000
+20.2%
1,678,375
-14.4%
0.00%
+50.0%
Q4 2020$36,659,000
+2.6%
1,961,405
-6.8%
0.00%0.0%
Q3 2020$35,747,000
-25.5%
2,105,259
+2.2%
0.00%
-33.3%
Q2 2020$47,998,000
+211.3%
2,060,903
+12.3%
0.00%
+200.0%
Q1 2020$15,420,000
-1.2%
1,835,735
+14.9%
0.00%0.0%
Q4 2019$15,612,000
+5.5%
1,597,948
+2.5%
0.00%0.0%
Q3 2019$14,796,000
-24.9%
1,559,101
-5.9%
0.00%0.0%
Q2 2019$19,694,000
-28.3%
1,657,732
+6.3%
0.00%
-50.0%
Q1 2019$27,468,000
+14.9%
1,559,799
+13.2%
0.00%0.0%
Q4 2018$23,916,000
+14.7%
1,377,667
-1.5%
0.00%0.0%
Q3 2018$20,852,000
+5.0%
1,399,303
+12.0%
0.00%0.0%
Q2 2018$19,865,000
+19.9%
1,249,154
+7.1%
0.00%
+100.0%
Q1 2018$16,566,000
-5.6%
1,166,456
-7.0%
0.00%0.0%
Q4 2017$17,554,000
+1.9%
1,254,149
+4.1%
0.00%0.0%
Q3 2017$17,221,000
-11.2%
1,204,324
-2.2%
0.00%
-50.0%
Q2 2017$19,390,000
+13.0%
1,231,092
-1.0%
0.00%0.0%
Q1 2017$17,164,000
-10.2%
1,243,847
+15.2%
0.00%0.0%
Q4 2016$19,118,000
+5.7%
1,080,077
+15.2%
0.00%0.0%
Q3 2016$18,090,000
+3.9%
937,646
+5.1%
0.00%0.0%
Q2 2016$17,403,000
-6.9%
892,460
-1.6%
0.00%0.0%
Q1 2016$18,702,000
-4.1%
907,378
-4.5%
0.00%0.0%
Q4 2015$19,503,000
+22.4%
950,510
+2.0%
0.00%0.0%
Q3 2015$15,928,000
-8.1%
931,491
+0.2%
0.00%0.0%
Q2 2015$17,329,000
-4.7%
929,614
-2.5%
0.00%0.0%
Q1 2015$18,186,000
+28.4%
953,317
+10.8%
0.00%
+100.0%
Q4 2014$14,162,000
-5.0%
860,349
+2.1%
0.00%
-50.0%
Q3 2014$14,905,000
-14.5%
842,630
-0.3%
0.00%0.0%
Q2 2014$17,442,000
-6.2%
845,227
-0.9%
0.00%0.0%
Q1 2014$18,593,000
-52.0%
853,077
-48.4%
0.00%0.0%
Q4 2013$38,746,000
+96.0%
1,654,195
+97.9%
0.00%0.0%
Q3 2013$19,770,000
+11.6%
835,984
+1.5%
0.00%0.0%
Q2 2013$17,709,000823,6980.00%
Other shareholders
MERIDIAN BIOSCIENCE INC shareholders Q3 2021
NameSharesValueWeighting ↓
SYQUANT CAPITAL SAS 134,804$4,47711.01%
Vazirani Asset Management LLC 115,774$3,8456.51%
FIFTH LANE CAPITAL, LP 185,914$6,174,2045.56%
NEXPOINT ASSET MANAGEMENT, L.P. 1,939,075$64,396,6815.01%
Crystalline Management Inc. 244,453$8,118,2844.08%
FNY Investment Advisers, LLC 51,000$1,6932.36%
HAVENS ADVISORS LLC 26,800$890,0282.26%
Euclidean Technologies Management, LLC 62,995$2,092,0641.99%
Sand Grove Capital Management LLP 537,060$17,8361.70%
Crabel Capital Management, LLC 120,337$3,9961.45%
View complete list of MERIDIAN BIOSCIENCE INC shareholders